International Cancer Prevention Society (ICAPS)

International Cancer Prevention Society: 10th International Conference on Lung Cancer Prevention

Immediately proceeding and held in conjunction with the 17th IASLC World Conference on Lung Cancer


20 Leading Experts Will Present in these Key Sessions Lung Cancer Chemoprevention Studies


  • New Agents Lung Cancer Risk –Tobacco & Beyond
  • Molecular Lung Cancer Screening & Early Detection
  • Novel Strategies for Smoking Cessation
  • Plenary Talk: Are We Ready for Phase III Prevention Trials in Lung Cancer?
  • Panel Discussion: Options for Lung Cancer Chemoprevention, Open Consensus Session


For more information please visit the event-website

Scientific need

Despite advances in treatment, lung cancer has been steadily increasing world-wide over the last several decades and remains the leading cause of cancer-related death. While research continues to produce encouraging developments in the treatment of lung cancer, prevention and early detection offers the most effective way to reduce death from lung cancer. This ICAPS conference will provide the collaborative atmosphere and educational framework to advance lung cancer prevention science, and will focus on the following principal topics and current challenges:


Principal Topics:

  • Current status of lung cancer prevention clinical trials
  • Lung cancer risk assessment
  • Advances in molecular screening for lung cancer
  • Current status of tobacco control policies



Objectives of the 2016 ICAPS Conference:

To promote communication between cancer prevention researchers and clinicians and to advance lung cancer prevention research. We will:

  1. Review current cancer prevention and early detection strategies for lung cancer.
  2. Facilitate interaction among scientists, and early cancer prevention scientists to interact with senior leaders in this field present at the iCAPS meeting and the World Congress.These interactions will stimulate research collaborations, and will stimulate research propelling the field of cancer prevention forward.
  3. Evaluate current evidence relating to lung cancer prevention, and produce consensus recommendations for future lung cancer prevention clinical trials.



Distinctive features of this year’s program include:

  • Exploration of potential vaccine strategies that target the nicotine receptor for lung cancer prevention
  • Examination of novel chemotherapy strategies that show high potential for being effective in preventing lung cancer
  • Organization of the meeting to be held in conjunction with the large-scale 17th World Conference on Lung Cancer (WCLC) to maximize attendance and opportunities for collaboration

Rorschacherstr. 150
CH-9006 St. Gallen/Switzerland
Tel. +41 (0)71 243 00 32
Fax. +41 (0)71 245 68 05